Axa S.A. Increases Stock Position in Cameco Co. (NYSE:CCJ)

Axa S.A. boosted its holdings in shares of Cameco Co. (NYSE:CCJ) (TSE:CCO) by 433.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,194 shares of the basic materials company’s stock after buying an additional 16,411 shares during the quarter. Axa S.A.’s holdings in Cameco were worth $1,038,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of CCJ. Sierra Ocean LLC bought a new position in shares of Cameco in the 4th quarter worth $25,000. Hurley Capital LLC purchased a new stake in shares of Cameco during the fourth quarter valued at about $27,000. Bank Julius Baer & Co. Ltd Zurich bought a new stake in shares of Cameco in the 4th quarter valued at about $28,000. Whipplewood Advisors LLC purchased a new position in shares of Cameco in the 4th quarter worth approximately $33,000. Finally, Compass Planning Associates Inc bought a new position in shares of Cameco during the 4th quarter worth approximately $36,000. Institutional investors own 70.21% of the company’s stock.

Cameco Price Performance

Shares of CCJ opened at $50.76 on Friday. The business’s 50-day moving average is $42.74 and its two-hundred day moving average is $48.97. The company has a market capitalization of $22.10 billion, a P/E ratio of 181.29 and a beta of 0.89. Cameco Co. has a fifty-two week low of $35.00 and a fifty-two week high of $62.55. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88.

Cameco (NYSE:CCJ) (TSE:CCO) last announced its quarterly earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). The company had revenue of $549.58 million during the quarter, compared to analyst estimates of $890.07 million. Cameco had a net margin of 5.39% and a return on equity of 4.34%. The company’s revenue was up 24.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share. Research analysts predict that Cameco Co. will post 1.27 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CCJ. StockNews.com lowered shares of Cameco from a “hold” rating to a “sell” rating in a report on Monday, May 5th. Glj Research upped their target price on Cameco from $62.76 to $75.68 and gave the company a “buy” rating in a research report on Wednesday, March 12th. Stifel Canada raised Cameco to a “strong-buy” rating in a report on Wednesday, March 12th. Sanford C. Bernstein initiated coverage on shares of Cameco in a report on Tuesday, April 1st. They set an “outperform” rating and a $52.00 price objective on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $90.00 target price on shares of Cameco in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and three have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $70.03.

Cameco Company Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.